Abstract:Atrial fibrillation is a clinically usual arrhythmia, which is a disturbance of atrial rhythm mainly arising from many small turnback rings caused by atrial dominant turnback ring. Among various reasons which induce the disease, inflammation proves to be an important one according to more and more studies at present. This paper mainly reviews the progress of researches related to atrial fibrillation and inflammation.
[1] Anderson JL, Halperin JL, Albert NM, et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2013, 61(18):1935-1944.[2] Jiang MH, Su YM, Tang JZ, et al. Angiotensinconverting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertension[J]. Clinics(Sao Paulo), 2013, 68(11):1428-1432.[3] Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association[J]. Eur Heart J, 2012, 33(21):2719-2747.[4] Pan M, Zhu JH, Jiang WP, et al. Inflammation: a possible pathogenic link to atrial fibrillation[J]. Med Hypotheses, 2006, 67(6):1305-1307.[5] Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2010, 31(19):2369-2429.[6] Hu D, Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China[J]. J Am Coll Cardiol, 2008, 52(10):865-868.[7] Toutouzas K, Synetos A, Drakopoulou M, et al. The role of inflammation in atrial fibrillation: a myth or a fact?[J]. Am J Med Sci, 2009, 338(6):494-499.[8] 郑金国, 邓新桃, 何永辉, 等. 心房颤动与白细胞介素-6的关系[J]. 江苏大学学报:医学版, 2010, 20(5):425-427.[9] 陈楚, 魏美芳, 潘闽. 肿瘤坏死因子α与心房颤动及左心房重构的关系[J]. 南通大学学报:医学版, 2012, 32(3):185-187.[10] Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves Creactive protein and is associated with postoperative arrhythmia[J]. Circulation, 1997, 96(10):3542-3548.[11] Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation[J]. Circulation, 1997, 96(4):1180-1184.[12] Yamashita T, Sekiguchi A, Iwasaki YK, et al. Recruitment of immune cells across atrial endocardium in human atrial fibrillation[J]. Circ J, 2010,74(2):262-270.[13] Aviles RJ, Martin DO, AppersonHansen C, et al. Inflammation as a risk factor for atrial fibrillation[J]. Circulation, 2003, 108(24):3006-3010.[14] Sata N, Hamada N, Horinouchi T, et al. Creactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?[J]. Jpn Heart J, 2004, 45(3):441-445.[15] Gedikli O, Dogan A, Altuntas I, et al. Inflammatory markers according to types of atrial fibrillation[J]. Int J Cardiol, 2007, 120(2):193-197.[16] Marcus GM, Smith LM, Ordovas K, et al. Intracardiac and extracardiac markers of inflammation during atrial fibrillation[J]. Heart Rhythm, 2010, 7(2):149-154.[17] Li J, Song J, Jiang MH, et al. Interleukin6 promoter polymorphisms and susceptibility to atrial fibrillation in elderly Han Chinese patients with essential hypertension[J]. J Interferon Cytokine Res, 2012, 32(11):542-547.[18] Alegret JM, Aragonès G, Elosua R, et al. The relevance of the association between inflammation and atrial fibrillation[J]. Eur J Clin Invest, 2013, 43(4):324-331.[19] Hagiwara N. Inflammation and atrial fibrillation[J]. Circ J, 2010, 74(2):246-247.[20] Gao SP, Deng XT, Ge LJ, et al. Is inflammation linked to thrombogenesis in atrial fibrillation?[J]. Int J Cardiol, 2011, 149(2):260-261.[21] Deng XT, Jiang MH, Zhu JH, et al. The association of interleukin 6634C/G polymorphism with left atrial thrombus and severe spontaneous echocontrast in patients with atrial fibrillation[J]. Clin Appl Thromb Hemost, 2013, 19(6):673-678.[22] Tsioufis C, Syrseloudis D, Hatziyianni A, et al. Relationships of CRP and P wave dispersion with atrial fibrillation in hypertensive subjects[J]. Am J Hypertens, 2010, 23(2):202-207.[23] Mazza A, Bendini MG, Cristofori M, et al. Creactive protein and Pwave in hypertensive patients after conversion of atrial fibrillation[J]. J Cardiovasc Med (Hagerstown), 2013, 14(7):520-527.[24] Kourliouros A, Savelieva I, Kiotsekoglou A, et al. Current concepts in the pathogenesis of atrial fibrillation[J]. Am Heart J, 2009, 157(2):243-252.[25] Lappega。rd KT, Hovland A, Pop GA, et al. Atrial fibrillation: inflammation in disguise?[J]. Scand J Immunol, 2013, 78(2):112-119.[26] Fauchier L, Pierre B, de Labriolle A, et al. Antiarrhythmic effect of statin therapy and atrial fibrillation a metaanalysis of randomized controlled trials[J]. J Am Coll Cardiol, 2008, 51(8):828-835.[27] Hung CY, Lin CH, Loh elW, et al. CHADS(2) score, statin therapy, and risks of atrial fibrillation[J]. Am J Med, 2013, 126(2):133-140.[28] Baran C,, Durdu S, Dalva K, et al. Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial[J]. Stem Cell Rev, 2012, 8(3):963-971.[29] Maggioni AP, Fabbri G, Lucci D, et al. Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSIHF trial[J]. Eur Heart J, 2009, 30(19):2327-2336.[30] Vermes E, Tardif JC, Bourassa MG, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials[J]. Circulation, 2003,107(23):2926-2931.[31] Kuhn EW, Liakopoulos OJ, Borys MJ, et al. Statins improve surgical ablation outcomes for atrial fibrillation in patients undergoing concomitant cardiac surgery[J]. Interact Cardiovasc Thorac Surg, 2010, 11(1):24-28.[32] GISSIAF Investigators, Disertori M, Latini R, et al. Valsartan for prevention of recurrent atrial fibrillation[J]. N Engl J Med, 2009, 360(16):1606-1617.[33] Goldstein RN, Ryu K, Khrestian C, et al. Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model[J]. J Cardiovasc Electrophysiol, 2008, 19(1):74-81.[34] Dernellis J, Panaretou M. Relationship between Creactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation[J]. Eur Heart J, 2004, 25(13):1100-1107.